{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:06Z","timestamp":1762868106629,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.cgh.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T11:14:59Z","timestamp":1586603699000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-2154","authenticated-orcid":false,"given":"Shawn L.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigeen H.","family":"Janisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian E.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.04.003_bib1","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable bowel syndrome","volume":"376","author":"Ford","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.003_bib2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41395-018-0256-8","article-title":"Burden of gastrointestinal symptoms in the United States: results of a nationally representative survey of over 71,000 Americans","volume":"113","author":"Almario","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.003_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.003_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/apt.14948","article-title":"Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome","volume":"48","author":"Lacy","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.003_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ajg.2011.485","article-title":"IBS patients' willingness to take risks with medications","volume":"107","author":"Lacy","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00019053-200220070-00003","article-title":"Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting","volume":"20","author":"Akehurst","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cgh.2020.04.003_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0149-2918(02)85143-8","article-title":"Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases","volume":"24","author":"Frank","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.cgh.2020.04.003_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1097\/MEG.0b013e328365abd3","article-title":"How patients with long-term experience of living with irritable bowel syndrome manage illness in daily life: a qualitative study","volume":"25","author":"Jakobsson Ung","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.003_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10880-008-9132-9","article-title":"Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder","volume":"15","author":"Seres","year":"2008","journal-title":"J\u00a0Clin Psychol Med Settings"},{"key":"10.1016\/j.cgh.2020.04.003_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.003_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.cgh.2020.04.003_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"10.1016\/j.cgh.2020.04.003_bib17","first-page":"207","article-title":"The standard gamble method: what is being measured and how it is interpreted","volume":"29","author":"Gafni","year":"1994","journal-title":"Health Serv Res"},{"key":"10.1016\/j.cgh.2020.04.003_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00005650-199607000-00004","article-title":"Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2","volume":"34","author":"Torrance","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.cgh.2020.04.003_bib19","series-title":"Readings in welfare economics","article-title":"On the measurement of utility of public works. Translated by Barback RH in International Economic Papers 1952;2:83\u2013110; from De la Mesure de l' Utilite des Travaux Publics. Ann Ponts Chaussees. 2nd series. 1844;8","author":"Dupuit","year":"1969"},{"key":"10.1016\/j.cgh.2020.04.003_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41395-018-0262-x","article-title":"Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem","volume":"113","author":"Fr\u00e4ndemark","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCG.0b013e318189a7f9","article-title":"International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit","volume":"43","author":"Drossman","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib22","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1038\/ctg.2014.18","article-title":"Medication risk-taking behavior in functional dyspepsia patients","volume":"6","author":"Lacy","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.003_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5489\/cuaj.2179","article-title":"Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS)","volume":"8","author":"Krsmanovic","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.cgh.2020.04.003_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpain.2003.08.003","article-title":"Catastrophizing and internal pain control as mediators of outcome in the multidisciplinary treatment of chronic low back pain","volume":"8","author":"Spinhoven","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1016\/j.cgh.2020.04.003_bib25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/AJP.0b013e3181bff800","article-title":"Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls","volume":"26","author":"Heymen","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cgh.2020.04.003_bib26","first-page":"435","article-title":"Depression and abdominal pain in IBS patients: the mediating role of catastrophizing","volume":"66","author":"Lackner","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.cgh.2020.04.003_bib27","doi-asserted-by":"crossref","first-page":"15417","DOI":"10.1503\/cjs.015417","article-title":"Can pain catastrophizing be changed in surgical patients? A scoping review","volume":"61","author":"Gibson","year":"2018","journal-title":"Can J Surg"},{"key":"10.1016\/j.cgh.2020.04.003_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1071-9164(95)90025-X","article-title":"Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death","volume":"1","author":"Rector","year":"1995","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cgh.2020.04.003_bib29","first-page":"1569","article-title":"Pain relief in osteoarthritis: patients' willingness to risk medication-induced gastrointestinal, cardiovascular, and cerebrovascular complications","volume":"34","author":"Richardson","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2020.04.003_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/bmj.325.7364.592","article-title":"Alosetron: a case study in regulatory capture, or a victory for patients' rights?","volume":"325","author":"Moynihan","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2020.04.003_bib31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2146\/news070044","article-title":"Novartis suspends tegaserod sales at FDA\u2019s request","volume":"64","author":"Thompson","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cgh.2020.04.003_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/j.gastro.2007.04.075","article-title":"Crohn's disease patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy","volume":"133","author":"Johnson","year":"2007","journal-title":"Gastroenterology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520304845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520304845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:32:58Z","timestamp":1761543178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520304845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1542356520304845"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.003","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}